Novartis To Make Its Medical Education Programs Virtual Under DOJ Settlement
Executive Summary
Two settlements totaling $729m resolve kickback claims related to speaker programs and copay charities; Novartis will limit payments to healthcare professionals for providing medical education under a new corporate integrity agreement.
You may also be interested in...
Biogen Agrees To One Of Largest FCA Settlements Without DOJ Intervention
Company to pay $900m to resolve claims it paid kickbacks to physicians to induce them to prescribe its multiple sclerosis drugs. Whistleblower sought damages based on the number of prescriptions written after a healthcare provider received a kickback from Biogen.
Alcohol, Repeat Attendees Could Raise Red Flags On Speaker Programs, OIG Attorney Says
Benjamin Wallfisch, a senior attorney at the Office of the Inspector General in the US Department of Health and Human Services, recently discussed how companies can avoid apparent violations of anti-kickback law while hosting educational programs.
COVID-19 Leads To Less Industry Spend On Docs, But Not Necessarily Less Influence
Drug and medical device company payments to doctors and hospitals for non-research related activities dropped for the first time in 2020 since CMS’s Open Payments database began collecting the information.